BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 25, 2008
View Archived Issues
Zogenix Eyes Public Markets, Files for Potential $86M IPO
Only days after the FDA accepted for review Zogenix Inc.'s new drug application for its needle-free sumatriptan candidate, the San Diego-based firm filed for an initial public offering. (BioWorld Today)
Read More
Cytokinetics Sees Shares Rise on Positive Heart Drug Data
Read More
Parkinson's Treated with SCNT as Genomics Data Find Home
Read More
NewCo News: Influmedix Plans to Go Multiple Rounds With M Channel Target
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Clinic Roundup
Read More